Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes
October 25, 2024

The University of Cincinnati's Alberto Espay commented to NBC News on new research published Oct. 24 that found semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes.